BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 10559988)

  • 1. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
    Brown NR; Noble ME; Endicott JA; Johnson LN
    Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
    Lowe ED; Tews I; Cheng KY; Brown NR; Gul S; Noble ME; Gamblin SJ; Johnson LN
    Biochemistry; 2002 Dec; 41(52):15625-34. PubMed ID: 12501191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell cycle inhibitor p21CIP is phosphorylated by cyclin A-CDK2 complexes.
    Jaumot M; Estañol JM; Casanovas O; Graña X; Agell N; Bachs O
    Biochem Biophys Res Commun; 1997 Dec; 241(2):434-8. PubMed ID: 9425288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
    Russo AA; Jeffrey PD; Patten AK; Massagué J; Pavletich NP
    Nature; 1996 Jul; 382(6589):325-31. PubMed ID: 8684460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.
    Schulman BA; Lindstrom DL; Harlow E
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10453-8. PubMed ID: 9724724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin B and cyclin A confer different substrate recognition properties on CDK2.
    Brown NR; Lowe ED; Petri E; Skamnaki V; Antrobus R; Johnson LN
    Cell Cycle; 2007 Jun; 6(11):1350-9. PubMed ID: 17495531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4.
    Leng X; Noble M; Adams PD; Qin J; Harper JW
    Mol Cell Biol; 2002 Apr; 22(7):2242-54. PubMed ID: 11884610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
    Saville MK; Watson RJ
    Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases.
    Wohlschlegel JA; Dwyer BT; Takeda DY; Dutta A
    Mol Cell Biol; 2001 Aug; 21(15):4868-74. PubMed ID: 11438644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of beta3-endonexin mutants for their ability to interact with cyclin A.
    Ohtoshi A; Otoshi H
    Mol Genet Genomics; 2001 Dec; 266(4):664-71. PubMed ID: 11810239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.
    Jeffrey PD; Russo AA; Polyak K; Gibbs E; Hurwitz J; Massagué J; Pavletich NP
    Nature; 1995 Jul; 376(6538):313-20. PubMed ID: 7630397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
    Schulze-Gahmen U; Jung JU; Kim SH
    Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of GSK3beta reveals a primed phosphorylation mechanism.
    ter Haar E; Coll JT; Austen DA; Hsiao HM; Swenson L; Jain J
    Nat Struct Biol; 2001 Jul; 8(7):593-6. PubMed ID: 11427888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DP1 phosphorylation in multimeric complexes: weaker interaction with cyclin A through the E2F1 cyclin A binding domain leads to more efficient phosphorylation than stronger interaction through the p107 cyclin A binding domain.
    Guida P; Zhu L
    Biochem Biophys Res Commun; 1999 May; 258(3):596-604. PubMed ID: 10329431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Picture story. Reining in CDK.
    Feng H
    Nat Struct Biol; 2001 May; 8(5):391. PubMed ID: 11323710
    [No Abstract]   [Full Text] [Related]  

  • 19. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
    Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
    Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle. Confirmational change.
    Pines J
    Nature; 1995 Jul; 376(6538):294-5. PubMed ID: 7630391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.